FUJIFILM Pharmaceuticals U.S.A.

FUJIFILM Pharmaceuticals U.S.A. is a clinical-stage pharmaceutical company and a subsidiary of the Fujifilm Group, dedicated to developing innovative treatments for oncology and other serious diseases. The company utilizes Fujifilm's proprietary core technologies, such as advanced chemical synthesis and nano-dispersion, to create novel drug candidates and delivery systems. Its pipeline includes small molecule inhibitors and radiopharmaceuticals targeting hematologic malignancies and advanced solid tumors. Based in Lexington, Massachusetts, the organization serves as a strategic hub for Fujifilm's pharmaceutical R&D and clinical development activities in the United States. The company aims to leverage its parent organization's expertise in materials science to address significant unmet medical needs in the global healthcare market.